UNLIMITED FREE
ACCESS
TO THE WORLD'S BEST IDEAS

SUBMIT
Already a GlobalSpec user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your GlobalSpec Experience

Finish!
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

CLSI C59

Apolipoprotein Immunoassays: Development and Recommended Performance Characteristics; Approved Guideline

active, Most Current
Buy Now
Organization: CLSI
Publication Date: 1 September 1997
Status: active
Page Count: 52
scope:

This document will address several issues which require particular attention. These include the following:

(1) Qualification and assessment of immunogen- Section 3.

(2) Polymorphism- Section 3.1.1.

(3) Antiserum specificity and titer- Sections 4, and 5.

(4) Storage conditions for patient samples- Section 6.3.

(5) Detergent requirements and effects-Section 6.5.

(6) Patient preparation- Section 7.

(7) Immunochemical methods- Section 8.

(8) Particle size effects- Section 8.1, and Section 8.3.

(9) Comparability of assay results among methods- Section 8.8.

(10) Storage conditions for reference materials- Section 9.

(11) Value assignment and transfer to reference materials- Section 9.

(12) Data management- Section 10 through Section 10.6.

(13) Interpretation of values- Section 12.

Document History

CLSI C59
September 1, 1997
Apolipoprotein Immunoassays: Development and Recommended Performance Characteristics; Approved Guideline
This document will address several issues which require particular attention. These include the following: (1) Qualification and assessment of immunogen— Section 3. (2) Polymorphism— Section 3.1.1....

References

Advertisement